China Journal of Leprosy and Skin Diseases ›› 2021, Vol. 37 ›› Issue (12): 801-803.doi: 10.12144/zgmfskin202112801

• Case Reports • Previous Articles     Next Articles

Treatment of childhood pustular psoriasis with ixekizumab: a case report

CHEN Zuoxi1,2, ZHANG Yuan2, ZHAO Qing2, SHI Zhongxiang2, SUN Yonghu2, ZHANG Furen2   

  1. 1 Cheeloo College of Medicine, Shandong University, Jinan 250012, China; 
    2 Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250022, China
  • Online:2021-12-15 Published:2021-09-29
  • Contact: ZHANG Furen, E-mail: zhangfuren@hotmail.com

Abstract: It has been reported that the occurrence and development of pustular psoriasis is related to IL-17A, and IL-17A antagonists can reverse the molecular biological process of psoriasis and improve the clinical symptoms of patients. Ixekizumab has been used to treat pustular psoriasis in adult, but there was no report of ixekizumab in the treatment of the child with pustular psoriasis. We report a case of 12-year-old girl with pustular psoriasis who responds well to ixekizumab treatment.

Key words: pustular psoriasis, childhood, ixekizumab